BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31924119)

  • 1. VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis.
    Low S; Wu H; Jerath K; Tibolla A; Fogal B; Conrad R; MacDougall M; Kerr S; Berger V; Dave R; Villalona J; Pantages L; Ahlberg J; Li H; Van Hoorick D; Ververken C; Broadwater J; Waterman A; Singh S; Kroe-Barrett R
    MAbs; 2020; 12(1):1709322. PubMed ID: 31924119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation.
    Rowinska Z; Koeppel TA; Sanati M; Schelzig H; Jankowski J; Weber C; Zernecke A; Liehn EA
    PLoS One; 2017; 12(2):e0170644. PubMed ID: 28234900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression.
    Herlea-Pana O; Yao L; Heuser-Baker J; Wang Q; Wang Q; Georgescu C; Zou MH; Barlic-Dicen J
    Cardiovasc Res; 2015 May; 106(2):324-37. PubMed ID: 25765938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
    Zhang H; Guo C; Wu D; Zhang A; Gu T; Wang L; Wang C
    PLoS One; 2012; 7(7):e41147. PubMed ID: 22815945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification.
    Yang T; Guo L; Chen L; Li J; Li Q; Pi Y; Zhu J; Zhang L
    Cell Calcium; 2020 Nov; 91():102265. PubMed ID: 32814243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
    Zhou JJ; Wang YM; Lee VWS; Zhang GY; Medbury H; Williams H; Wang Y; Tan TK; Harris DCH; Alexander SI; Durkan AM
    PLoS One; 2018; 13(4):e0195657. PubMed ID: 29641559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
    Zhang H; Guo C; Zhang A; Fan Y; Gu T; Wu D; Sparatore A; Wang C
    Eur J Pharmacol; 2012 Dec; 697(1-3):106-16. PubMed ID: 23085268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells.
    Shen F; Zhang Y; Jernigan DL; Feng X; Yan J; Garcia FU; Meucci O; Salvino JM; Fatatis A
    Mol Cancer Res; 2016 Jun; 14(6):518-27. PubMed ID: 27001765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
    Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
    Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.
    Combadière C; Potteaux S; Gao JL; Esposito B; Casanova S; Lee EJ; Debré P; Tedgui A; Murphy PM; Mallat Z
    Circulation; 2003 Feb; 107(7):1009-16. PubMed ID: 12600915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial Protective Monocyte Patrolling in Large Arteries Intensified by Western Diet and Atherosclerosis.
    Quintar A; McArdle S; Wolf D; Marki A; Ehinger E; Vassallo M; Miller J; Mikulski Z; Ley K; Buscher K
    Circ Res; 2017 May; 120(11):1789-1799. PubMed ID: 28302649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E6130, a Novel CX3C Chemokine Receptor 1 (CX3CR1) Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1
    Wakita H; Yanagawa T; Kuboi Y; Imai T
    Mol Pharmacol; 2017 Nov; 92(5):502-509. PubMed ID: 28842393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link.
    Pucci S; Mazzarelli P; Zonetti MJ; Fisco T; Bonanno E; Spagnoli LG; Mauriello A
    Biomed Res Int; 2013; 2013():451349. PubMed ID: 24307998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography-Based Imaging-Brief Report.
    Li W; Luehmann HP; Hsiao HM; Tanaka S; Higashikubo R; Gauthier JM; Sultan D; Lavine KJ; Brody SL; Gelman AE; Gropler RJ; Liu Y; Kreisel D
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1030-1036. PubMed ID: 29567678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CX
    Sutti S; Bruzzì S; Heymann F; Liepelt A; Krenkel O; Toscani A; Ramavath NN; Cotella D; Albano E; Tacke F
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
    Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
    Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner.
    Barlic J; Zhang Y; Murphy PM
    J Biol Chem; 2007 Jun; 282(26):19167-76. PubMed ID: 17456471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.
    Lin JD; Nishi H; Poles J; Niu X; Mccauley C; Rahman K; Brown EJ; Yeung ST; Vozhilla N; Weinstock A; Ramsey SA; Fisher EA; Loke P
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractalkine/CX3CR1 and atherosclerosis.
    Liu H; Jiang D
    Clin Chim Acta; 2011 Jun; 412(13-14):1180-6. PubMed ID: 21492740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.